Patent · US Active

Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide

US8937042B2 · kind B2 · utility

0Cited by

4References

3Claims

0Family size

Assignee

Novo Nordisk A/S · DK

Inventors

Anne Plum · Nørresundby, DK
Dorte Bjerre Steensgaard · Copenhagen, DK
Jens Kaalby Thomsen · Hellerup, DK
Morten Schlein · Copenhagen, DK
Anne Sofie MARKUSSEN
Christian Poulsen · Copenhagen, DK

Key dates

Filing date	Nov 14, 2008
Grant date	Jan 20, 2015
Priority date	—
Expiry date	Apr 3, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.